SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739104-22-000017
Filing Date
2022-11-08
Accepted
2022-11-08 09:07:49
Documents
77
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elan-20220930.htm   iXBRL 10-Q 1785613
2 EX-31.1 ex311elanco-20220930xceoce.htm EX-31.1 10301
3 EX-31.2 ex312elanco-20220930xcfoce.htm EX-31.2 10305
4 EX-32 ex32elanco-20220930xsectio.htm EX-32 8891
10 elan-20220930_g1.jpg GRAPHIC 68307
  Complete submission text file 0001739104-22-000017.txt   7683346

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elan-20220930.xsd EX-101.SCH 46786
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elan-20220930_cal.xml EX-101.CAL 76520
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elan-20220930_def.xml EX-101.DEF 240790
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elan-20220930_lab.xml EX-101.LAB 575581
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elan-20220930_pre.xml EX-101.PRE 377165
71 EXTRACTED XBRL INSTANCE DOCUMENT elan-20220930_htm.xml XML 1312702
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38661 | Film No.: 221367445
SIC: 2834 Pharmaceutical Preparations